版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
COMBATINGCOUNTERFEITDRUGSININDONESIAFirstASEAN-ChinaConferenceonCombatingCounterfeitMedicalProductsJakarta,13-15November2007NationalAgencyofDrugandFoodControlIndonesiaBACKGROUNDlocatedbetweentwocontinentsandtwooceans,whichiseasilyaccessiblebyland,sea,orair.someproblemsarestillbeingfaced,blemsmayarisefromborderlineareas,whicharesusceptibletosmuggled,counterfeitmedicines.RegardingcounterfeitmedicinestheymaybeIllegallyimportedorLocallymanufacturedbyillegalmanufacturerINDONESIADistributedtoillegalmarketFREETRADEZONEFreeTradeZoneBATAM,includingBatamIsland,TontonIsland,SetotokIsland,NipahIsland,RempangIsland,GalangIslandandGalangBaruIsland.FreeTradeZoneBINTAN,includingGalangBatangIndustrialEstate,MaritimIndustrialEstate,andLobanIsland,SenggarangIndustrialEstateandDompakBaratIndustrialEstateFreeTradeZoneKARIMUN,includingnumberofKarimunIsland,KarimunAnakIslandFreeTradeZoneSABANG.NUMBEROFINTERNATIONALPORTSEAPORT:141AIRPORT:10
LEGISLATIVE
INFRASTRUCTUREBORDERPOSTEffortshavebeentakenbyestablishingBorderPostsinsomeareas,i.e:SKOU(PapuaNewGuinea)MOTAAIN,NAPAN&METAMAUK(TimorLeste)MARORE&MIANGAS(Philipine)ENTIKONG&JAGOIBABANG(EastMalaysiaLand)NUNUKAN(EastMalaysiaOcean)SUNGAIGUNTUNG(WestMalaysiaOcean)SAMBUBELAKANG,PADANG&TAREMPA(WestMalaysiaOcean)Objective:
TocontrolimportedgoodsTominimizeillegal&counterfeitdrugsenteringthecountryDefinitionCounterfeitDrugs(CD’s)definitioninIndonesiabasedonIndonesianMoHDecreeNo.949/2000:Amedicinalproductwhichismanufacturedbyillegalmanufacturerordeliberatelymislabeledwithrespecttoidentityofregisteredproduct.BasicLawandRegulationrelateddrugcounterfeitingLawNo.1/1946onCriminalActLawNo.23/1992onHealthLawNo.8/1999onConsumerProtectionLawNo.14/2001onPatentLawNo.15/2001onMarkNUMBEROFCASESCOUNTERFEITDRUGSFINDINGFREQUENCIES
PERIOD2001-2007(October)frequency*Thedataismadefromfindingfrequencies>3timesCounterfeitdrugsNUMBEROFCASESSUSPECTEDCONFIRMEDIMPORTED/DOSMETICVITALMEDICAL20072*2ImportandDomesticYes200611DomesticNo200533DomesticYes(injectable)*aresultofjointoperationwherebyanillegalwarehousewasfoundfilledwiththousandofboxesof26itemsofcounterfeitmedicines,withanestimatedvalueofupto25billionrupiahsHOWWHERETHESECASESDETECTED%ornumberofcasesPatientscomplaintsNODATAAVAILABLEHealthprofessionalsreportsNODATAAVAILABLEEnforcement/investigationworkNODATAAVAILABLERoutinechecksNODATAAVAILABLEReportedbyaffectedmanufacturer28,6%(2005),20%(2006),4,16%(2007)NUMBEROFPROSECUTIONS/CONVICTIONS/PENDINGMANUFACTURERWHOLESALER/IMPORTERRETAILERINFORMALSECTOR20071(inprocess)1(inprocess)2006--1(inprocess)-2005--3(2Sentencepenalty,1WantedList)-NADFCDATANATIONALCOORDINATIONMechanismofnationalcoordination
CombatingCounterfeitDrugsrequiresjointeffortDrug/NationalRegulatoryAuthorityHealthcare&medicineprovidersCivilsocietiesPatientInterestGroupsPatients/consumersDrugmanufacturersimporters&wholesalersmedicinesMinistries,police,customs,ProsecutorsGovernmentmedicinesBENEFITS&LIMITATIONSOFCOORDINATIONBENEFITSTechnicalsupportsuchaslaboratorytest,expertwitnessstatementwillbeprovidedbyNADFCifneededIffacingdifficulties,forceeffortwillbeprovidedbythePoliceProvidedinformationofimport-registeredproductsforthecustomSeveralLawsandregulationasbasiclegalprocesstocombatCounterfeitDrugsareavailableLIMITATIONSLackofthereferencestandardavailableinNQCLLackofcoordinationamonglawenforcementagenciesatalllevel(National-provincial-district)On-linesystemisnotinplaceWeaknessofImplementationofsomeLaws,suchasneedappealfromthemanufacturingauthorizationholderofauthenticdrugsSTRATEGICACTIONONCOMBATINGCOUNTERFEITDRUGS(CDs)inINDONESIAILEGALMANUFACTURERILLEGALMARKETILEGALDISTRIBUTORCONSUMERFACTS:CDsarefound,mostlyinillegalmarketDifficulttodifferenciatewiththegenuineoneLackofpublicawareness(consumersbuydrugsintheillegalmarket)STRATEGIES:BreakinguptheIllegalchainSustainablelawenforcementwithdeterrentpenaltiesRevealmodusoperandi,identifytheintellectualactorsandtheirnetwork
NationalProgram;Comprehensiveinvestigationandmopping-upwhatisalreadyincirculationNationalJointOperationandjointinvestigatinwithpolice(inilegalmarket)StrenghteningtheinfrastructureImprovementcollaborationandcoordinationwithotherlawenforcementagenciesIncreasingcomprehensivedrugdistributioncontrolIncreasingpublicawarenessandlawenforcementagenciesREGIONALLEVELGAPSIMPLICATIONSSTRATEGYInter-sectoralcoordinationisnotbasedonwrittenprocedurewhichareclearlydefinedroles,adequateresourcesandeffectiveadministrativeandoperationaltools.Lackofawarenessabouttheseverityoftheproblemamongstakeholder.NospecificlawonCounterfeitDrugs.LimitationofreferencestandardonNQCLNocomprehensiveprogramoncombatingcounterfeitdrugsNodeterrentsanctionsNodeterrentsanctionsThetimelineoflabresultisnotonscheduleDevelopnationaltskforceoninter-sectoralcoordinationbaseonwrittenprocedures,clearlydefinedroles,adequateresources,andeffectiveadministrativeandoperationaltools.Increasingawarenessontheharmful/impactofcounterfeitdrugsthroughseminarforthespecifictargetgroupssuchasPharmaceuticalManufacturer,Healthprofessionals,patients,trainingforLawenforcementAgencies,andDRAAssistnationalauthoritiestodevelopriskcommunicationandadvocacymaterialsDevelopdraftoncounterfeitdrugsLawNeedcollaborationtogetreferenceatandardassistbyWHOREGIONALLEVELGAPSIMPLICATIONSSTRATEGYLackofInformationExchangeamongcountries,nodesignatedpersoninchargeatDRADifferentdefinitionofCounterfeitDrugsamongCountriesLackofnetworkingonCounterfeitdrugsproblemamongASEANDRAs
difficultiesoncontactingthepersoninchargeDifferentfollowupactiondifficultytoknowthegenuityofthesuspecteddrugDifficultytotracethesuspectiftheyescapetoothercountriesPromotenetworkingandcollaborationamongASEANDRAoncounterfeitdrugsDevelopTORwhichareincludediscussionamongASEANcountrieson:thedefinitionofcounterfeitdrugs.Surveyexistingnationalandinternationallegislation&requirementsAssessexistingnationalbestpracticesanddevelopmodelbestpracticesPromotesecureexchangeofinformationandalertsamongASEANDRADevelopmentofcommondefinitionofcounterfeitdrugwithinASEANCountriesDevelopmentASEANSchemeontacklingofcounterfeitdrugsDevelopmentaRegionalStrategyandSystematicProgramProposedProjectagainstCounterfeitDrugsOUTPUTExchangeofinformationbydesignatedunitofDRADevelopdatabaseofcounterfeit
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024-2030年撰寫(xiě):中國(guó)動(dòng)物大腦提取膽固醇行業(yè)發(fā)展趨勢(shì)及競(jìng)爭(zhēng)調(diào)研分析報(bào)告
- 2024-2030年撰寫(xiě):中國(guó)α戊基桂醇項(xiàng)目風(fēng)險(xiǎn)評(píng)估報(bào)告
- 2024-2030年抗堿封閉底面處理劑搬遷改造項(xiàng)目可行性研究報(bào)告
- 2024-2030年山東省煤炭產(chǎn)業(yè)發(fā)展?fàn)顩r投資規(guī)模分析報(bào)告權(quán)威版
- 2024-2030年國(guó)家甲級(jí)資質(zhì):中國(guó)京式炸雞爐融資商業(yè)計(jì)劃書(shū)
- 2024-2030年史地桌公司技術(shù)改造及擴(kuò)產(chǎn)項(xiàng)目可行性研究報(bào)告
- 2024-2030年雙級(jí)制冷壓縮機(jī)公司技術(shù)改造及擴(kuò)產(chǎn)項(xiàng)目可行性研究報(bào)告
- 2024-2030年冷凍梁系統(tǒng)行業(yè)市場(chǎng)現(xiàn)狀供需分析及重點(diǎn)企業(yè)投資評(píng)估規(guī)劃分析研究報(bào)告
- 2024-2030年全球及中國(guó)輝光放電質(zhì)譜儀(GDMS)市場(chǎng)銷(xiāo)售態(tài)勢(shì)與營(yíng)銷(xiāo)渠道分析報(bào)告
- 2024-2030年全球及中國(guó)自燃點(diǎn)測(cè)試儀行業(yè)發(fā)展?fàn)顩r及投資前景預(yù)測(cè)報(bào)告
- 大學(xué)無(wú)機(jī)及分析化學(xué)----氣體練習(xí)題及答案
- 北師大版數(shù)學(xué)初二上冊(cè)知識(shí)點(diǎn)總結(jié)
- 鐵路建設(shè)項(xiàng)目施工企業(yè)信用評(píng)價(jià)辦法(鐵總建設(shè)〔2018〕124號(hào))
- 模具報(bào)價(jià)表精簡(jiǎn)模板
- 形式發(fā)票模板 PI模板 英文版
- 初一的最美的風(fēng)景高分的作文600字
- 高考英語(yǔ)單項(xiàng)選擇題題庫(kù)題
- 檢驗(yàn)檢測(cè)機(jī)構(gòu)資質(zhì)認(rèn)定現(xiàn)場(chǎng)評(píng)審日程表及簽到表
- 完整版高低壓開(kāi)關(guān)柜投標(biāo)文件技術(shù)標(biāo)
- 蘭州市行政區(qū)劃代碼表
- 管鮑之交-歷史劇劇本(共4頁(yè))
評(píng)論
0/150
提交評(píng)論